NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.22M | -1.99M | -2.22M | -1.79M | -2.10M |
| Total Depreciation and Amortization | 129.70K | 129.60K | 133.10K | 132.80K | 161.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.90K | 71.20K | 196.80K | 50.00K | 52.30K |
| Change in Net Operating Assets | -78.20K | -142.10K | -158.80K | 8.40K | 180.50K |
| Cash from Operations | -2.12M | -1.93M | -2.05M | -1.59M | -1.70M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -84.30K | -10.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -84.30K | -10.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.70M | -- | 6.07M | 1.25M | 728.10K |
| Repurchase of Common Stock | -- | -6.70K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.70M | -6.70K | 6.07M | 1.25M | 728.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -419.10K | -1.94M | 4.02M | -432.90K | -984.00K |